There is an opportunity for GenAI to help bring better and safer drugs to market faster and more cost-efficiently, ...
Life sciences and healthcare companies will have to focus on seeing consumers as more than patients, according to a recent ...
The St. Louis-based private equity firm's portfolio company, a producer of containers for the life science industry, has ...
Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to ...
As AI becomes more prevalent, organizations need to leverage the power of scope, scale, speed, and human-AI collaboration for ...
Artificial intelligence and the accessibility that generative AI offers are a tsunami rushing through the tech sector.
Scientists are designing simplified biological systems, aiming to construct synthetic cells and better understand life’s ...
(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world ...
Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in ...
The Company's revenues in the 2024 period of $31.9 million improved year-over-year by 3%. Enzo’s sales to its industrial customers, which includes biotech and pharmaceutical companies, increased 46% ...
CNN on MSN9d
Endocrine-disrupting chemicals are everywhere and could have many health impacts, researchers sayThe chemicals are called EDCs, and they are likely already in your home. Here’s what researchers know about their potential ...
The Supreme Court of California is gearing up to decide an important question for the future of product liability law: Do drug manufacturers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback